skip to main content

ALK Positive Summit Blood Collection

Meet the patients where they are: A new perspective on translational research in the field to accelerate precision oncology

Contributed by Stacy Fry, Stacy Fry, B.S., CCRP Program Manager; Angel Qin, M.D., Clinical lead and co-PI of JTARI and Sofia D. Merajver, M.D., Ph.D., Scientific Lead and co-PI of JTARI

Medical students promote skin cancer prevention in Ann Arbor

University of Michigan Medical School students asked young people what was stopping them from using sunscreen more often. They learned young people were well aware of the importance of sunscreen and the cancer risk that comes with repeated sunburns — the problem was, though, that sunscreen just wasn’t handy when it was needed.

Last Mile Initiative hopes to improve access to HPV testing

The Last Mile Initiative is a partnership through the National Cancer Institutes to assess effectiveness of self-collection based HPV testing for cervical cancer.

Research finds issues with accessibility to cancer care

Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their first phone call to a clinic.

Reducing chemoradiation in some patients is possible, research finds

Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center. This could assist many patients in a quicker return to their normal lives.

Promising new drug may improve ability to treat rare head and neck cancers

Experts at University of Michigan Health Rogel Cancer Center have conducted the first study evaluating the effectiveness of a targeted drug for patients with salivary gland cancers (SGC).

Studying cells to improve medulloblastoma treatment

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with medulloblastoma, an aggressive childhood cancer.

Resistance to cancer therapies may be blocked by new drug candidate

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.

Novel biomarker linked to renal cancer recurrence identified

Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.

Pages